Benign breast tissue composition in breast cancer patients: Association with risk factors, clinical variables, and gene expression

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 12, 2014, Pages 2810-2818

  Sun, Xuezheng ^a   Sandhu, Rupninder ^b   Figueroa, Jonine D ^c   Gierach, Gretchen L ^c   Sherman, Mark E ^c   Troester, Melissa A ^a,b  

^a The University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST; BREAST CANCER; BREAST EPITHELIUM; CANCER PATIENT; CLINICAL FEATURE; CYTOKINE RESPONSE; FEMALE; GENE EXPRESSION; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; OBESITY; RISK FACTOR; STROMA; BREAST TUMOR; CASE CONTROL STUDY; GENETICS; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HUMANS; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 84919343253     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0507     Document Type: Article

References (43)

1. Wiseman BS, Werb Z. Stromal effects on mammary gland development and breast cancer. Science 2002; 296: 1046-9.
2. Robinson GW, Karpf AB, Kratochwil K. Regulation of mammary gland development by tissue interaction. J Mammary Gland Biol Neoplasia 1999; 4: 9-19.
3. Russo J, Romero AL, Russo IH Architectural pattern of the normal and cancerous breast under the influence of parity. Cancer Epidemiol Biomarkers Prev 1994; 3: 219-24.
4. Ghosh K, Brandt KR, Reynolds C, Scott C.G., Pankratz VS, Riehle DL, et al. Tissue composition of mammographically dense and non-dense breast tissue. Breast Cancer Res Treat 2012; 131: 267-75.
5. Couto E, Qureshi SA, Hofvind S, Hilsen M., Aase H, Skaane P, et al Hormone therapy use and mammographic density in postmenopausal norwegian women. Breast Cancer Res Treat 2012; 132: 297-305.
6. Bissell MJ, Hines WC Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med 2011; 17: 320-9.
7. Polyak K, Kalluri R. The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb Perspect Biol 2010; 2:a003244.
8. Kass L, Erler JT, Dembo M, Weaver VM Mammary epithelial cell: Influence of extracellular matrix composition and organization during development and tumorigenesis. Int J Biochem Cell Biol 2007; 39: 1987-94.
9. Barcellos-Hoff MH. Stromal mediation of radiation carcinogenesis. J Mammary Gland Biol Neoplasia 2010; 15: 381-7.
10. Campbell LL, Polyak K. Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell Cycle 2007; 6: 2332-8.
11. Polyak K. Breast cancer: Origins and evolution. J Clin Invest 2007; 117: 3155-63.
12. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: A meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 1159-69.
13. Jezierska-Drutel A., Rosenzweig SA, Neumann CA Role of oxidative stress and the microenvironment in breast cancer development and progression. Adv Cancer Res 2013; 119: 107-25.
14. Reisfeld RA. The tumor microenvironment: a target for combination therapy of breast cancer. Crit Rev Oncog 2013; 18: 115-33.
15. Place AE, Jin Huh S, Polyak K. The microenvironment in breast cancer progression: Biology and implications for treatment. Breast Cancer Res 2011; 13:227.
16. Gertig DM, Stillman IE, Byrne C, Spiegelman D., Schnitt SJ, Connolly JL, et al. Association of age and reproductive factors with benign breast tissue composition. Cancer Epidemiol Biomarkers Prev 1999; 8: 873-9.
17. Li T, Sun L, Miller N., Nicklee T, Woo J, Hulse-Smith L, et al. The association of measured breast tissue characteristics with mammo-graphic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 343-9.
18. Sun X, Gierach GL, Sandhu R, Williams T., Midkiff BR, Lissowska J, et al. Relationship of mammographic density and gene expression: Analysis of normal breast tissue surrounding breast cancer. Clin Cancer Res 2013; 19: 4972-82.
19. Garcia-Closas M., Brinton LA, Lissowska J, Chatterjee N., Peplonska B, Anderson WF, et al Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer 2006; 95: 123-9.
20. Camp JT, Elloumi F, Roman-Perez E, Rein J., Stewart DA, Harrell JC, et al. Interactions with fibroblasts are distinct in basal-like and luminal breast cancers. Mol Cancer Res 2011; 9: 3-13.
21. Byng JW, Boyd NF, Fishell E, Jong R.A., Yaffe MJ. The quantitative analysis of mammographic densities. Phys Med Biol 1994; 39: 1629-38.
22. Hastie TJ TR. Generalized additive models. 1st ed. New York: Chapman and Hall; 1990.
23. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3:Article3.
24. Casbas-Hernandez P., D Arcy M, Roman-Perez E, Brauer H.A., McNaughton K., Miller SM, et al. Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ. Breast Cancer Res 2013; 15:R82.
25. Finak G, Sadekova S, Pepin F., Hallett M, Meterissian S, Halwani F., et al. Gene expression signatures of morphologically normal breast tissue identify basal-like tumors. Breast Cancer Res 2006; 8:R58.
26. Yang XR, Chang-Claude J, Goode E.L., Couch FJ, Nevanlinna H, Milne RL, et al Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the breast cancer association consortium studies. J Natl Cancer Inst 2011; 103: 250-63.
27. Yang XR, Figueroa JD, Falk R.T., Zhang H., Pfeiffer RM, Hewitt SM, et al. Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers. Breast Cancer Res 2012; 14:R64.
28. Ghosh K, Hartmann LC, Reynolds C, Visscher DW, Brandt KR, Vierkant RA, et al. Association between mammographic density and age-related lobular involution of the breast. J Clin Oncol 2010; 28: 2207-12.
29. Pirone JR, D'arcy M, Stewart DA, Hines W.C., Johnson M., Gould MN, et al. Age-associated gene expression in normal breast tissue mirrors qualitative age-at-incidence patterns for breast cancer. Cancer Epidemiol Biomarkers Prev 2012; 21: 1735-44.
30. Ginsburg OM, Martin LJ, Boyd NF Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer 2008; 99: 1369-74.
31. Beck AH, Sangoi AR, Leung S, Marinelli R.J., Nielsen TO, van de Vijver MJ, et al. Systematic analysis of breast cancer morphology uncovers stromal features associated with survival. Sci Transl Med 2011; 3: 108ra113.
32. Dekker TJ, van de Velde CJ, van Pelt GW, Kroep JR, Julien JP, Smit VT, et al. Prognostic significance of the tumor-stroma ratio: Validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854). Breast Cancer Res Treat 2013; 139: 371-9.
33. Downey CL, Simpkins SA, White J, Holliday D.L., Jones JL, Jordan LB, et al. The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer. Br J Cancer 2014; 110: 1744-7.
34. Gnerlich JL, Yao KA, Fitchev P.S., Goldschmidt RA, Bond MC, Cornwell M, et al Peritumoral expression of adipokines and fatty acids in breast cancer. Ann Surg Oncol 2013; 20:S731-8.
35. Boyd NF, Martin LJ, Li Q, Sun L., Chiarelli AM, Hislop G, et al. Mam-mographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 961-6.
36. Walker RA, Martin CV The aged breast. J Pathol 2007; 211: 232-40.
37. Bulun SE, Mahendroo MS, Simpson ER Aromatase gene expression in adipose tissue: relationship to breast cancer. J Steroid Biochem Mol Biol 1994; 49: 319-26.
38. Hawes D, Downey S, Pearce C.L., Bartow S., Wan P, Pike MC, et al Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity. Breast Cancer Res 2006; 8:R24.
39. Morishita M, Ohtsuru A, Hayashi T., Isomoto I, Itoyanagi N, Maeda S., et al. Clinical significance of categorisation of mammographic density for breast cancer prognosis. Int J Oncol 2005; 26: 1307-12.
40. Razzaghi H, Troester MA, Gierach G.L., Olshan AF, Yankaskas BC, Millikan RC. Association between mammographic density and basal-like and luminal A breast cancer subtypes. Breast Cancer Res 2013; 15: R76.
41. Brauer HA, Makowski L, Hoadley K.A., Casbas-Hernandez P, Lang LJ, Roman-Perez E, et al. Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer. Clin Cancer Res 2013; 19: 571-85.
42. Troester MA, Lee MH, Carter M, Fan C., Cowan DW, Perez ER, et al. Activation of host wound responses in breast cancer microenvironment. Clin Cancer Res 2009; 15: 7020-8.
43. Sherman ME, Figueroa JD, Henry J.E., Clare SE, Rufenbarger C, Storniolo AM. The Susan G. Komen for the cure tissue bank at the IU Simon Cancer Center: a unique resource for defining the "molecular histology" of the breast. Cancer Prev Res 2012; 5: 528-35.